Blue Horseshoe Stocks: HMNY Review & More

Helios and Matheson Analytics, Inc. HMNY

We’ve been watching HMNY for awhile now, and tagged the stock in yesterday morning’s premarket report. While it didn’t exactly go to the moon, we were quite pleased with the solid performance it put forth on the day.

It coincided with the company’s announcement that it had obtained licensing rights to a facial recognition technology developed in Israel. The stock traded up from a low of 3.65 to as high as 4.90, which marks a move of 34% and it came on an incredible 285X the 30-day average volume.

That kind of surge in liquidity is sure to produce some interesting results that we will be eager to track as we head through midweek.

Pilgrim Petroleum Corp. PGPM

Despite its ‘Limited Information’ designation on OTC Markets, we began tracking PGPM last Tuesday the 16th, at which time we observed a low of .0059 in the stock.

Since then it has been stepping its way up and yesterday, briefly touched a high of .02, which marked a one-week swing of 239%  We’ll be on the lookout for PGPM to continue its overall trend,, remaining interested as long as it maintains support at or above .01 on any pullbacks.

Chatroom Call – Las Vegas Railway Express XTRN

We’ll always jump at the chance to remind readers that in addition to these premarket reports, we also conduct daily live in-session trader’s chats via Skype*.

Yesterday, thanks to chat participant Steve, the room was alerted on XTRN and subsequently had a chance at gains of up to 300% as the stock ran from .0003-.0012.

XTRN then closed at its high-of-day on monster volume, so we will want to keep an eye on it today for a potential continuation of momentum.

*Do you subscribe to our mailing list? If so, you’re eligible to participate and/or observe our daily trader’s chats! Simply send a contact request to username ‘stocksumo’ and we’ll take care of the rest.

Extended Watchlist:

Blue Horseshoe Stocks: CNAT Recap & More

Conatus Pharmaceuticals, Inc. CNAT

We were fairly confident that at least one of the pharma news plays we put forth in yesterday’s premarket report would turn out a promising session, and CNAT definitely rose to the occasion.

We highlighted it, of course, because of a big collaboration and licensing deal for one of the company’s drugs, which adds a quick $50M cash to the books almost immediately, and even more down the road.

After gapping up considerably in the premarket, the stock underwent a dip-and-rip scenario which carried it to a daily low of 4.27 before it pushed its way up to a high of 5.50. That marked a solid intraday upswing of 29% and came on four times the three-month average volume.

ACADIA Pharmaceuticals, Inc. ACAD

ACAD was the other play off of our pharma watchlist that provided us with significant opportunities, which were even bigger than the previously mentioned stock.

We offered an options idea, the ACAD Weekly $28-31 Calls, and all but a couple sets of contracts in that range produced respectable intraday moves.

$28 Calls – Range: .70-1.66 – Max Gain: 137%
$28.50 Calls – Range: .59-1.40 – Max Gain: 137%
$29 Calls – Range: .40-.80 – Max Gain: 100%
$29.50 Calls – Range: .30-.70 – Max Gain: 133%
$30 Calls – Range: .18-.50 – Max Gain: 178%


NIKE, Inc. NKE – Fresh Options Idea

NKE is coming off a post-market earnings beat yesterday, so we want to enter an idea into the logs for this situation.

We’re going to be monitoring the activity in the NKE Weekly $52.50-54 Calls for possible daytrades and/or swing trades into the end of the week.

Extended Watchlist:

Blue Horseshoe Stocks: Pharma Watchlist & More

Actinium Pharmaceuticals, Inc. ATNM

We want to start things off this morning by taking a look at ATNM, for a couple of reasons. First, from a technical standpoint, the chart appears to be coming off of a relative bottom, and a number of indicators suggest that a sizable upswing could occur in coming sessions.

Those include a MACD and Histogram that look to be gearing up for a possible cross into bullish territory. Each of the past two times that occurred, the stock saw an appreciable move to the upside. The RSI also looks to be coming off of being oversold- we’ll be looking for a break of that 50-line, and the registering of higher lows and higher highs as ATNM attempts to establish a continued trend off of its recent lows.

The other factor that is indirectly drawing us to ATNM is the fact that it operates in the Pharma sector, which is sure to be at the forefront of the news with a couple of huge buyouts. Pfizer has bought Anacor (ANAC) and Luminex bought Nanosphere (NSPH). Whenever we see groundbreaking events happening in biopharma, there tends to be a rise in overall activity for the industry.

That’s why, in addition to ATNM, we’ll be placing the following couple of stocks on watch as we kick off another trading week: Inovio Biomedical, Inc. INO, and Sorrento Therapeutics, Inc. SRNE

3D Systems Corp. DDD

After an impressive run-up on the chart which lasted from January to April, DDD has taken a pretty substantial pounding in the month of May.

The stock came down to bounce off of its 200DMA on Thursday, and recorded higher highs and higher lows on Friday. We’ll look for a continuation of that trend into today, and monitor DDD for a possible recovery. We will need to see the stock hold support at or above the current 200DMA of 11.73 on any pullbacks in order for it to hold our interest. A return to its PPS levels from the end of April from this juncture would produce potential gains of at least 50%

Extended Watchlist:
STVF, ELTP, CSOC, GSAT, BCEI, PTX(Coming Off Bottom)

Incoming search terms:

  • fro com ino

Blue Horseshoe Stocks: FCEL, AQXP Recaps & More

Aquanox Pharmaceuticals, Inc. AQXP

AQXP was among the stocks that we presented in yesterday’s premarket report, as we were catching it a couple of days after some really positive developments were announced by the company. Despite already being up significantly at that point, our instincts to include it in our daily interests proved to be well-founded.

The stock made a monstrous move right out of the starting gate from 17.56-55.75, a walloping 217% initial rip, followed by an extreme pullback. The activity in AQXP was so abnormally volatile that trading was temporarily halted. AQXP stock is presently gapping up in premarket trading as high as 38.74 so far this morning.

Familiar Bottom-Bouncers

Yesterday was an interesting session in that we noticed an unusually high number of stocks with which we are very familiar, making some excellent moves off of their recently-attained low-points.

FuelCell Energy, Inc. FCEL – FCEL had been on a continuous backslide for many weeks. The company released a positive PR (Link Below) and things took off from there, as you can see on the included chart. We’ll be looking for the stock to maintain at least half of the advance it made yesterday on any pullbacks.


Inovio Pharmaceuticals, Inc. INO

INO also had a big day generated by a PR. The company entered into a partnership with AstraZeneca to provide its cancer treatment in a deal that could reportedly bring as much as $700M in revenue INO’s way. (>>>Get More Details). We are well-acquainted with this stock, having last mentioned it just a couple of weeks ago. We’ll be keen to track the ensuing activity after yesterday’s major revelation, and roughly 30% increase on the day.


Other stocks that we routinely discuss that also made appreciable moves off of relative lows yesterday were Voltari Corp. VLTC, Dominovas Energy Corp. DNRG, and Ascent Solar Technologies, Inc. ASTI. Those familiar bottom-bouncers were joined by New Source Energy Partners. NSLP, a newcomer to our reports. We’ll be watching the whole lot as the week progresses. Continued gains, as well as possible dip-and-rip scenarios could be in the cards for any and/or all of them!

Fresh Options Ideas

We’ve got a nice selection of new options-trading possibilities to enter into the mix today:

Shake Shack, Inc. SHAK -  Shake Shack beat on earnings  yesterday and is gapping up in the premarket today. As a result we are going to be taking a look at Weekly $72-76 Calls for potential chances at intraday/intraweek flips.

Apple, Inc. AAPL -  We’ve had a lot of success with AAPL Options in both the distant and recent past, and a new, longer-term idea to monitor in coming weeks is going to be the Sept. 18th $120-122 Calls.

Twitter, Inc. TWTR - For a prospective idea in the TWTR chain, we’ll stretch our target period out to that same Sept. 18th expiration, and track the 9/18 TWTR $30-32 Calls.

Blue Horseshoe Stocks: SOPW News, PTN on Bottom Watch

Solar Power, Inc. SOPW

SOPW is the first of a couple of news plays that we’re going to be taking a look at this morning. The company has announced the initiation of a 6-month long share repurchase program wherein it will obtain up to $50M of its common stock from the open market.

Xiaofeng Peng, Chairman of SPI stated, “The implementation of our share repurchase program reflects the confidence that our Board and management have in SPI’s growth prospects and our commitment to enhance value for our shareholders while retaining adequate flexibility for future growth.” >>> READ FULL PR

In addition to the favorable PR that, in and of itself would be enough to gain our attention, SOPW has also been searching for a bottom over the past few weeks, and we’ll want to be hanging around when it finds one, as the subsequent rebound could be considerable.

Palatin Technologies, Inc. PTN

PTN has capitalized on the FDA’s recommendation for the first ever treatment for a disorder that affects the female sex drive. The company itself has a similar treatment that is currently enrolling women for Phase-3 trials.

As a result of this heightened attention, this morning, the stock is gapping up over 50% in the premarket. We’re going to tag it for observation, because the potential for a dip-and-rip in situations like these is ever-present.

LinkedIn Corp. LNKD -  Options

Our LNKD Weekly Options Calls that we brought into the mix on Wednesday continued to pay dividends for the second consecutive session yesterday. We wanted to give a quick update on the ranges and total gains that have been possible with those contracts over a two-day span:

$205′s – Range: 6.00-11.64 – Max Gain: 94%
$207.50′s – Range: 4.20-9.29 – Max Gain: 119%
$210′s – Range: 2.60-7.30 – Max Gain: 181%
$212.50′s – Range: 1.58-5.10 – Max Gain: 223%

We want to extend our congratulations to anyone who joined us in taking advantage of the trend in LNKD this week. It wasn’t the first time we’ve made successful options calls on this stock, and it probably won’t be the last.

Extended Watchlist:

Incoming search terms:

  • stock ticks jdst